Abstract：【Objective】To investigate the risk factors of pulmonary complications after thoracoscopic radical resection of lung cancer.【Methods】A total of 55 patients with postoperative pulmonary complications who underwent thoracoscopic radical resection of lung cancer in our hospital from May 2014 to May 2017 were randomly selected as the complication group. A total of 60 patients without postoperative pulmonary complications after thoracoscopic radical resection of lung cancer at the same time were randomly selected as the control group. The relevant elements of general clinical data were set as observation variables to analyze the influencing factors of pulmonary complications after thoracoscopic radical resection of lung cancer.【Results】Age, smoking, chronic obstructive pulmonary disease (COPD), preoperative peak expiratory flow rate, and perioperative respiratory function exercise compliance were all independent factors influencing the occurrence of pulmonary complications after radical resection of thoracoscopic lung cancer (OR=1.153、1.252、1.358、0.593、1.923). 【Conclusion】Advanced age, smoking and combined COPD were independent risk factors for pulmonary complications after radical thoracoscopic lung cancer surgery, while preoperative peak expiratory flow rate and perioperative respiratory function exercise were protective factors to avoid pulmonary complications, which provided a reference for clinical individualization prediction of postoperative pulmonary complications.
车强, 汪林宝, 王孝彬, 王律. 胸腔镜肺癌根治术后肺部并发症发生风险分析[J]. 医学临床研究, 2020, 37(11): 1667-1670.
CHE Qiang, WANG Lin-bao, WANG Xiao-bin, et al. Risk Factors Analysis of Pulmonary Complications after Thoracoscopic Radical Resection of Lung Cancer. JOURNAL OF CLINICAL RESEARCH, 2020, 37(11): 1667-1670.
[1] Comacchio GM, Schiavon M, Azzolina D, et al. Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections[J].World J Surg,2019, 43(5):1385-1392. [2] Li X, He Y, Zhu J, et al. Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review[J].Oncotarget,2018, 9(72):33734-33738. [3] 栗景坤, 李习, 刘美娜. 基于评价指标的非小细胞肺癌治疗质量影响因素分析[J].中国医院统计, 2018, 25(6): 405-409. [4] Clavien PA, Strasberg SM. Severity Grading of Surgical Complications[J].Ann Surg,2009, 250(2):197-198. [5] 施庆彤, 刁亚利, 钱军. 单孔胸腔镜手术联合ERAS理念指导下的呼吸功能锻炼在肺癌围手术期的应用[J].中国肺癌杂志, 2020, 23(8): 667-672. [6] Sato S, Shimizu Y, Goto T, et al. Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study[J].BMC Pulm Med,2018, 18(1):134. [7] Singer ES, Merritt RE, D'Souza DM, et al. Patient satisfaction after lung cancer surgery: Do clinical outcomes affect hospital consumer assessment of health care providers and systems scores?[J].Ann Thorac Surg,2019, 108(6):1656-1663. [8] Yasuura Y, Maniwa T, Mori K, et al. Quantitative computed tomography for predicting cardiopulmonary complications after lobectomy for lung cancer in patients with chronic obstructive pulmonary disease[J].Gen Thorac Cardiovasc Surg,2019, 67(8):697-703. [9] Meng S, Yang F, Dai F, et al. Effect of a high intensive preoperative rehabilitation on the perioperative complications in patients with chronic obstructive pulmonary disease eligible for lung cancer surgery[J].Zhongguo Fei Ai Za Zhi,2018, 21(11):841-848. [10] Iwasawa T, Okudela K, Takemura T, et al. Computer-aided quantification of pulmonary fibrosis in patients with lung cancer: relationship to disease-free survival[J].Radiology, 2019, 292(2):489-498. [11] Choucair K, Kelso JD, Duff JR, et al. Interleukin 10-mediated response and correlated anemia in a patient with advanced non-small cell lung carcinoma[J].Case Rep Oncol,2019, 12(1):297-303. [12] Szpechcinski A, Florczuk M, Duk K, et al. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients[J].Cell Mol Life Sci,2019, 76(18):3641-3656. [13] Check JH, Check D, Poretta T. Mifepristone extends both length and quality of life in a patient with advanced non-small cell lung cancer that has progressed despite chemotherapy and a check-point inhibitor[J].Anticancer Res,2019, 39(4):1923-1926. [14] Yang L, Yao T, Liu G, et al. Monitoring and control of medical air disinfection parameters of nosocomial infection system based on internet of things[J].J Med Syst,2019, 43(5):126. [15] 陈春雨, 顾江魁, 葛圣林. 术前呼气峰流速对肺癌患者肺叶切除术后肺部并发症预测价值的研究[J].天津医药,2020, 48(2): 115-118. [16] 王洪武, 黄琳惠, 蔡兴俊, 等. 有创-无创序贯机械通气治疗AECOPD合并Ⅱ型呼吸衰竭患者的临床疗效及影响因素[J].山东医药, 2020, 60(13): 79-82. [17] Islam T, Kubra K, Hassan Chowdhury MM. Prevalence of methicillin-resistant staphylococcus aureus in hospitals in Chittagong, Bangladesh: A threat of nosocomial infection[J].J Microsc Ultrastruct,2018, 6(4):188-191.
2020, Vol. 37 
